Normal Weight, Overweight and Obesity
Conditions
Keywords
cinnamon, insulin, glucose, postprandial, acute
Brief summary
The objective of the proposed study is to investigate the effect of cinnamon on the postprandial glycemic response to a high glycemic index meal in normal and overweight/obese prediabetic subjects
Detailed description
A randomized crossover study design will be carried out in accordance with the guidelines of the Human Subjects Protection Committee of the University of California, Los Angeles. All subjects will give written informed consent before the study begins. There will be two groups of participants (normal and overweight/obese). Each participant will consume oatmeal prepared with 1 cup of 2% milk served with or without 6 g of ground cinnamon in random sequence. At each meal consumption blood will be collected to measure postprandial glucose and insulin at 0, 30, 60, 90, 120, 150 and 180 minutes.
Interventions
DIETARY_SUPPLEMENTcinnamon
6 g of ground cinnamon
Sponsors
University of California, Los Angeles
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* Healthy human adults age 20-50 years' old * Typically consume low fiber/polyphenol diet (beige diet) * normal weight individuals with a BMI of 18. to 24.9 kg/ m2 with fasting serum glucose \<100 mg/dL * overweight/obese individuals with a BMI of 25 to 35 kg/m2 and fasting serum glucose ≥100 mg/dL and \<126 mg/dL or HbA1c \>5.7% and \< 6.5%. * Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.
Exclusion criteria
* Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator. * Any subject currently taking blood thinning medications such as Warfarin or Coumadin * Any history of gastrointestinal disease or surgery except for appendectomy or cholecystectomy. * Eating a high fiber/polyphenol diet or taking any medication or dietary supplement which interfere with the absorption of polyphenols. * History of gastrointestinal surgery, diabetes mellitus, or other serious medical condition, such as chronic hepatic or renal disease, bleeding disorder, congestive heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery bypass graft, angioplasty within 6 months prior to screening, current diagnosis of uncontrolled hypertension (defined as systolic BP \>160mmHg, diastolic BP \>95mmHg), active or chronic gastrointestinal disorders, bulimia, anorexia, laxative abuse, or endocrine diseases (except thyroid disease requiring medication) as indicated by medical history. * Pregnant or breastfeeding * Currently uses tobacco products. * Currently has an alcohol intake \> 20 g ⁄ day; * Currently has a coffee intake \> 3 cups ⁄ day; * Allergy or sensitivity to cinnamon. Subjects will be excluded if there is a prior history of such sensitivity. Since these foods are commonly eaten and allergies are rare, subjects should be aware of this sensitivity prior to entering the study. To determine this, a positive history of cinnamon ingestion without incident will be requested. In addition, any subject with a history of allergy or anaphylaxis of any kind will be excluded * Is lactose intolerant * Is unable or unwilling to comply with the study protocol.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| glucose | Baseline to 180 minutes | postprandial glucose reponse |
| insulin | Baseline to 180 minutes | postprandial insulin response |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| C-peptide | Baseline to 180 minutes | postprandial C-peptide response |
| glucagon | Baseline to 180 minutes | postprandial glucagon reponse |
| lipids | Baseline to 180 minutes | postprandial lipid response |
Countries
United States
Outcome results
None listed